Therapeutic Asset Ratings
7,021 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cyclophosphamide
Estrogen-Receptor Negative Breast Cancer
Massachusetts General Hospital
P3
BB
(70)
Cyclophosphamide
Germ Cell Tumor
M.D. Anderson Cancer Center
P3
BB
(70)
Cyclophosphamide
HIV Infectious Disease
AIDS Malignancy Consortium
P3
BB
(70)
Cyclophosphamide
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer Center
P3
BB
(70)
Cyclophosphamide
Philadelphia Chromosome Positive
City of Hope Medical Center
P3
BB
(70)
Cyclophosphamide
Plasma Cell Neoplasm
Affiliated Hospital to Academy of Military Medical Sciences
P3
BB
(70)
Cyclophosphamide
Progesterone-Receptor Negative Breast Cancer
Massachusetts General Hospital
P3
BB
(70)
Cyclophosphamide
T-Cell Non-Hodgkin Lymphoma
GC Cell Corporation
P3
BB
(70)
Cyclophosphamide
Squamous Cell Lung Carcinoma
UNC Lineberger Comprehensive Cancer Center
P3
BB
(70)
Cyclophosphamide
Stage IV Pancreatic Cancer AJCC v8
TME Pharma AG
P3
BB
(70)
Cyclophosphamide
Untreated Adult Acute Myeloid Leukemia
City of Hope Medical Center
P3
BB
(70)
CYCLOSPORIN A
Childhood Acute Myeloid Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P3
BB
(70)
Cytosin-Arabinosid
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)
P3
BB
(70)
Cytosin-Arabinosid
Acute Undifferentiated Leukemia
Fred Hutchinson Cancer Center
P3
BB
(70)
Cytosin-Arabinosid
Disease Related To Hematopoietic Stem Cell Transplant
The First Affiliated Hospital of Soochow University
P3
BB
(70)
Cytosin-Arabinosid
Plasma Cell Myeloma
The Affiliated People's Hospital of Ningbo University
P3
BB
(70)
Cytosin-Arabinosid
Myeloid Sarcoma
Kura Oncology, Inc.
P3
BB
(70)
Cytosin-Arabinosid
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(70)
DACARBAZINE
Melanoma
Suzhou BlueHorse Therapeutics Co., Ltd.
P3
BB
(70)
Dasatinib
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P3
BB
(70)
Daunorubicin
Acute Basophilic Leukemia
National Cancer Institute (NCI)
P3
BB
(70)
Daunorubicin
Childhood Acute Lymphoblastic Leukemia
Children's Mercy Hospital Kansas City
P3
BB
(70)
Daunorubicin
Leukemia
Richard Stone, MD
P3
BB
(70)
Daunorubicin
Myelodysplastic Syndrome
OHSU Knight Cancer Institute
P3
BB
(70)
Dccr
Prader-Willi Syndrome
Soleno Therapeutics, Inc.
P3
BB
(70)
Showing 426 to 450 of 7,021 assets
Previous
Page 18 of 281
Next